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Introduction
Marek’s disease (MD) induced by Marek’s disease virus (MDV) 
is a T cell lymphoma in chickens and other birds. The disease is 
characterized by infiltration of proliferating lymphoid cells into 
many tissues1 and is also a unique natural model for lympho-
mas that overexpress Hodgkin’s antigen (CD30) in humans.2 
Although vaccines against MD have been developed, vaccina-
tion efforts have driven the virus to greater virulence. MDV 
infection is divided into four different phases. The entry of virus 
to target cells initiates early cytolytic infection from 3–7 days 
post infection (DPI). Latent infection starts at 7–8 DPI and 
primarily occurs at activated CD4+ T cells. Late lytic infection 
is reactivated from latency around 2–3 weeks post infection in 
susceptible chickens, and then switches to the transformation 
stage with observed lymphoid tumors in chickens.3 Thus, the 
late cytolytic stage is a critical step for MD progression and 
disease outcome. As with many viruses, MDV infection induces 
changes in DNA methylation patterns in the hosts and virus 
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itself that contribute to MD progression by activating or silenc-
ing genes crucial for MD immunity.4-6
In somatic cells, DNA methylation usually occurs at CG 
dinucleotides (CpG sites), and is catalyzed by the three DNA 
methyl-transferases, including DNMT1 for maintaining meth-
ylation and the de novo methyltransferases DNMT3a and 
DNMT3b. Inhibition of DNMTs contributes to DNA demeth-
ylation through a passive mechanism.7 Methylation is associ-
ated with the repression of transcription and is essential for key 
biological processes, including development, X-chromosome 
inactivation, imprinting and tissue specific gene expression.8 
Tissue-specific variations in DNA methylation patterns have 
been observed. In addition, abnormal DNA methylation con-
tributes to disease, including cancer and infectious disease.5,7,9 
In a normal vertebrate genome, the genome is primarily heav-
ily methylated except for CpG dense promoters. Methylome 
analysis in a variety of cancer cells has shown that DNA meth-
ylation levels decrease genome-wide, including hypomethyl-
ation in repetitive regions, while some tumor suppressor genes 
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enrichment of methylated DNA, sodium bisulfite conversion 
and enzymatic digestion.12 To study MDV induced methyla-
tion fluctuation in MD resistant and susceptible chickens, we 
adopted a recently developed method called Methyl-MAPS 
(methylation mapping analysis by paired-end sequencing).13 
This method yields high-resolution information with no bias 
toward the CpG rich regions: both single-copy and repetitive 
regions are directly probed. Our previous studies revealed that 
DNMTs were differentially expressed in the line 6
3
 and line 7
2
 
chickens,14 especially at 21 DPI, when the virus was reactivated 
from the latent stage.6,15,16 The results point to a profound dis-
tinction between epigenetic profiles and expression of selected 
genes in line 6
3
 and 7
2
 chickens. The interesting finding that 
many of these differences, particularly in response to MDV 
challenge, affect genes of the immune system or tumor pro-
gression and related pathways provides a strong rationale for 
pursuit of our hypothesis that epigenetic signatures are associ-
ated with resistance or susceptibility of MDV induced tumori-
genesis. In this study, global methylation levels were found to 
differ between non-infected 6
3
 and 7
2
 lines, and were reduced 
after MDV infection in line 6
3
. Analysis of differential methyla-
tion regions induced by MDV infection (iDMRs) suggests that 
DNA methylation likely regulates distinct pathways in resistant 
and susceptible chickens. We further demonstrate that drugs 
that inhibit DNA methylation repressed the spread of MDV in 
vitro. Collectively, DNA methylation is an important regulator 
of MD resistance and susceptibility, and these findings improve 
are observed to become hypermethylated.10 DNA methylation 
alterations have been observed in host-virus interactions, such 
as those identified in Epstein-Barr virus (EBV) transformed 
lymphoblastoid cell lines.11 Proper maintenance of DNA meth-
ylation likely plays a vital role to prevent tumorigenesis and dis-
ease progression.
To explore the role of DNA methylation in MD immunol-
ogy, two inbred chicken lines were used. Most birds in line 7
2
 
develop tumors after MDV infection, while line 6
3
 is resistant 
to the disease. Both lines have the same major histocompatibil-
ity complex (MHC) haplotype but show significantly different 
MD incidences after MDV infection, which allows us to exam-
ine mechanisms of MD resistance. DNMTs were found to be 
differentially regulated in line 6
3
 and 7
2
 after MDV infection, 
suggesting that promoter methylation alterations are triggered 
by the infection.6 DNA methylation was lost at active promoters 
in MDV carrying T cell lines and MD tumors, and was present 
in some CpG regions in MDV genome.6 However, conclusions 
from these studies were limited since they focused on methyl-
ation variations at specific loci. Genome-wide alterations have 
not yet been proved.
The emergence of next generation sequencing (NGS) pro-
vides a unique opportunity to understand global methyla-
tion variation following MDV infection in MD resistant and 
susceptible chickens. Since DNA methylation cannot be reli-
ably directly detected, several approaches are available for 
genome-wide methylation analysis, including antibody affinity 
Figure 1. Quantification of chicken DNMT expression. Expression of DNMT1, DNMT3a and DNMT3b was measured by qRT-pcR in thymus samples from 
non-infected and infected line 63 and line 72 chickens, and normalized to GApDh. The quantitative results are represented as mean ± sEM (n = 4). A 
single asterisk (p values < 0.05) and double asterisks (p values < 0.01) indicate the transcription level in the specific group was significantly different 
when compared with the adjoined group. L72.inf, infected line 72; L72.non.inf, non-infected line 72; L63.non.inf, non-infected line 63; L63.inf, infected line 
63.
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line 6
3
 (p < 0.05), and increased ~6% in infected line 7
2
 chickens 
(p > 0.05) (Fig. 2B). In addition, we found sweeping decreases 
in the methylation levels of individual CpG sites (Fig. 2A). This 
difference was interpreted by a lost of methylation in line 6
3
 and 
a slight gain of methylation in line 7
2
 after infection (Fig. 3). 
In line 6
3
, about two thirds of the methylated CpGs became 
unmethylated, and the proportion of unmethylated CpGs was 
increased 1.5 times after MDV infection.
The average methylation of CGIs was reduced in line 6
3
 from 
0.16 to 0.09 after MDV infection, and was slightly increased in 
the infected line 7
2
 from 0.16 to 0.20. The methylation levels 
of promoter CGIs were reduced in line 6
3
 after MDV infection, 
from 0.13 to 0.06. Overall promoter CGI methylation was stable 
in line 7
2
, with an average methylation level of 0.16 before and 
after infection. Methylation levels were similar between infected 
and uninfected line 7
2
 at promoter regions, and were higher in 
infected line 7
2
 than in uninfected chickens in the gene body 
(Fig. 4). In the resistant line 6
3
, methylation across gene bod-
ies was reduced 0.2 after infection (Fig. 4). For example, the 
methylation of 19 CpGs ~200 bp upstream of GATA2 (GATA 
binding protein 2) decreased from 53.1% to 34.6% in line 6
3
 
after MDV infection, and only reduced 2% in line 7
2
 (Fig. S1A 
and B). In the MHCII loci, methylation was increased in region 
1, and reduced in region 2 in line 7
2
 after the infection. These 
two regions did not show methylation variations in line 6
3
 after 
infection (Fig. 5A). Examination of repetitive DNA methylation 
revealed hypomethylation in line 6
3
 (0.24) and increased meth-
ylation in line 7
2
 (0.5). For example, methylation in region 3 was 
dramatically upregulated in line 7
2
, but was stable in line 6
3
 after 
infection. In the CGI nearby, methylation was downregulated 
in both lines after MDV infection, and line 7
2
 chickens showed 
higher methylation than line 6
3
.
Differential methylation regions (DMRs) in non-infected 
chickens. To identify methylation variation, we defined differ-
ential methylation regions (DMRs) as those regions in which 
the methylation difference was greater than 0.3 in a 200–300 bp 
window size with more than 3 CpG sites. Prior to infection, 
3,080 DMRs were discovered between two lines, and methyl-
ation levels were about 15% higher in line 7
2
 than in line 6
3
. 
These DMRs covered 530 RefSeq genes and 478 were found in 
repetitive DNA. To understand their potential function, path-
way analysis was applied to DMR-associated genes. We found 
that these genes were enriched in pathways, including interferon 
signaling, iNOS signaling and cell cycle, and diseases such as 
inflammatory diseases and cancer (Table 1). To explore the regu-
latory function of DMRs, DMRs were mapped to promoters of 
RefSeq genes. Ninety-nine DMRs were located in the promoters 
of 97 genes, which suggest they may negatively control transcrip-
tion. For example, a DMR was identified upstream of CDC42 
(cell division cycle 42), a protein involved in cell cycle regula-
tion, which was 10% less methylated in line 6
3
 (Fig. S2A and B). 
Correspondingly, the mRNA level of CDC42 was 12% higher in 
line 6
3
 than in line 7
2
 (Fig. S2C).
Infection induced differential methylation regions (iDMRs). 
To better understand methylation variation at individual loci, we 
determined infection induced differential methylation regions 
our understanding of the role of DNA methylation in infectious 
diseases and viral-infection induced tumors.
Results
Expression of DNMTs in MDV-infected and non-infected 
chickens. To test the influence of MDV infection on DNMT 
expression, the mRNA levels of each of the three DNA methyl-
transferases were examined by qPCR in the thymus of lines 6
3
 
and 7
2
 at 21 DPI as shown in Figure 1. While transcriptional lev-
els of DNMT1 were ~20% higher in line 7
2
 compared with line 
6
3
 (p > 0.05), DNMT1 expression was not significantly altered in 
either line after MDV exposure. DNMT3a mRNA was similar 
in non-infected line 6
3
 and line 7
2
. However, its expression was 
repressed by 30% in infected line 6
3
 chickens (p < 0.05). The 
expression of DNMT3b was 2 fold higher in line 7
2
 than in line 
6
3
 before MDV infection (p > 0.05), and its transcription was 
further activated in line 7
2
, by a ~50% increase after MDV infec-
tion (p > 0.01).
DNA methylation in MD-resistant and -susceptible 
chickens. To understand the biological consequence of DNMT3a 
and DNMT3b expression variations, DNA methylation global 
levels were measured using 5-mC dot blots and methylation was 
mapped genome-wide using Methyl-MAPS in MDV-infected and 
non-infected line 6
3
 and line 7
2
. Prior to infection, the average 
methylation level was higher in line 7
2
 (0.44) than in line 6
3
 (0.39) 
(Fig. 2A and B). In agreement, the distribution of methylation 
levels in the sequencing data were shifted downwards in line 6
3
. 
To explore how methylation was altered among each of the four 
samples, we categorized the CpG sites as methylated (methylation 
level greater than 75%), intermediately methylated (25–75%), and 
unmethylated (< 25%). Based on this criterion, the initial meth-
ylation differences were attributed to more methylated CpGs in 
line 7
2
 and more moderately methylated CpGs in line 6
3
 (Fig. 3). 
We also analyzed the methylation difference according to their 
distribution in the genome. Generally, methylation levels in CpG 
islands (CGIs) were similar in both lines, 0.16 in line 6
3
 and 0.13 
in line 7
2
, before infection. Meta-gene analysis of the methylation 
patterns across gene regions is plotted in Figure 4.
In addition to global changes, we found methylation differ-
ences at a variety of loci in the two lines. For example, differential 
methylation was identified in MHCII (major histocompatibility 
complex II) (Fig. 5A). MHCII is one of the determinants for MD 
resistance, and its haplotype is the same between line 6
3
 and line 
7
2
. Prior to MDV infection, region 1 was less methylated in line 
7
2
 than line 6
3
, and methylation levels were similar in region 2. 
In repetitive DNA regions, the average methylation levels were 
0.42 in both lines; however, we found methylation variation at 
individual loci. For example, the long-terminal repeat (LTR) 
(region 3, Fig. 5B) were highly methylated in uninfected line 
6
3
, and unmethylated in uninfected line 7
2
. The CGI (region 4, 
Fig. 5B) near the LTR was highly methylated in line 7
2
, and 
showed intermediate methylation in line 6
3
.
DNA methylation change induced by MDV infection. 
Methylation alterations were triggered by MDV infection in line 
6
3
 and line 7
2
. Methylation levels decreased ~38% in infected 
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Figure 2. (A) Boxplots of methylation levels for the detected cpGs. The y-axis was the methylation levels for all cpG sites calculated as the number of 
reads from methylated (RE) library divided by the number of reads from both methylated and unmethylated (McrBc) libraries. L72.inf: infected line 72; 
L72.non: non-infected line 72; L63.non: non-infected line 63; L63.inf: infected line 63. p values (B) Quantification of 5-mc content by anti-5-mc dot blot. 
The 5-mc content was measured in DNA from thymus using dot blot, shown as (mean ± sTD, n = 4). A single asterisk (p values < 0.05) indicated the 
5-mc contents in the specific group was significantly different when compared with other groups. L72.inf: infected line 72; L72.non: non-infected line 
72; L63.non: non-infected line 63; L63.inf: infected line 63.
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in line 6
3
, while iDMRs identified line 7
2
 were associated with 
genes functioning in cancer (Table 3).
DNA demethylation. It is possible that, in addition to the 
decrease in DNMT expression, active demethylation could contrib-
ute to the observed reduction in global methylation levels observed 
in line 6
3
 after MDV infection. To explore such a possibility, we 
measured global levels of 5-hmC, the intermediate of a potential 
active demethylation pathway (Fig. 6A and B). 5-hmC content in 
10 μg DNA sample from any of the chicken lines was found to 
be lower than the content of 5-hmC in 10 ng of positive control. 
5-hmC content decreased slightly in both 6
3
 and 7
2
 infected chick-
ens, indicating that this is not likely to contribute to the mecha-
nism of demethylation observed in line 6
3
 infected chickens.
Methylation inhibition and MDV infection in vitro. Due 
to the decreased DNA methylation on MD-resistant line 6
3
, it 
is reasonable to speculate that methylation was involved in the 
MD resistance phenotype. To explore the role of DNA methyla-
tion on MDV infection, the methylation inhibitor 5-azacytidine 
(5-AZA) was used to treat MDV infected DF-1 cells. As shown 
in Figure 7A, we found that the virus genome contents declined 
40–57% in infected cells in the presence of 5-AZA relative to 
the untreated control cells (p < 0.05) (Fig. 7A). In addition, the 
MDV oncoprotein Meq, which is expressed in most cells in the 
control group, was absent in some drug treated cells (Fig. 7B).
Global mapping of DNA methylation in chickens. Methyl-
MAPS was used to uncover the methylome in MD resistant and 
(iDMRs). In line 6
3
, there were 3,180 iDMRs, which overlapped 
with 1,247 RefSeq genes and 524 were found in repetitive DNA. 
In line 7
2
, 8,332 iDMRs were identified, which covered 3,079 
genes and 1,568 repeats. Methylation levels were decreased about 
5% in line 6
3
 and increased 25% in line 7
2
, respectively, after 
MDV infection. Among iDMRs, 94.6% of iDMRs in lines 6
3
 
overlapped with iDMRs in line 7
2
, which contains 884 genes 
and 1,496 repeated sequences. Of the iDMRs that were different 
between the two lines, many were at repeats such as the iDMR 
in line 7
2
 found at a CR1-B repeat on chromosome 3 (Fig. S3A 
and B). We also identified an iDMR in the promoter of GH 
(growth hormone), a previously identified candidate gene of MD 
resistance. The methylation level was higher in line 7
2
 than in line 
6
3
 before MDV infection, and methylation was reduced ~0.52 in 
line 7
2
 and decreases ~0.43 in line 6
3
 after infection (Fig. S4). 
The iDMR upstream of CDC42 (cell division cycle 42) existed in 
line 7
2
, with methylation decreasing from 64.5% to 31% (Fig. S2A 
and B). The same region did not show any methylation differ-
ences in line 6
3
 after infection. CDC42 transcription was upregu-
lated by ~24% in line 7
2
 after MDV infection (p < 0.05), and was 
similar in line 6
3
 (Fig. S2C). iDMR-related genes were enriched 
in different pathways in line 6
3
 and 7
2
, such as the IL-4 signaling, 
Myc mediated apoptosis signaling, and IGF-1 signaling in line 6
3
, 
and PDGF pathway and erythropoietin signaling in line 7
2
 (Table 
2A). Ingenuity systems pathway analysis (IPA) showed that genes 
associated with iDMRs were enriched in inflammatory response 
Figure 3. The classification of cpG based on the methylation levels. The cpGs were divided into 3 categories based on the methylation levels greater 
than 75% (Methy), 25–75% (Inter) and < 25% (Unmethyl). The number on the top of each bar represented the number of analyzed cpGs, and the 
percentage of cpGs in each category was labeled in the bar. L72.inf, infected line 72; L72.non, non-infected line 72; L63.non, non-infected line 63; L63.inf, 
infected line 63.
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unevenly distributed in different genomic compartments. Nearly 
one third of annotated CpGs were found in CpG islands. About 
18.43% of CpGs were in the annotated promoter regions, includ-
ing 16.73% of them in promoters within CGIs and 1.70% in 
the promoters lacking CGIs. We identified 26.95% of CpG sites 
located in gene bodies and 14.67% in repetitive DNA regions. 
Annotated CpG distributions were similar among the four sam-
ples (Table S4), which allowed us to compare methylation altera-
tions induced by MDV infection in these two chicken lines.
We also calculated methylation based on the genomic loca-
tion of CpGs. A total of 1,622,778 CpGs were located among 
the 22,806 CGIs in the chicken genome, and one third of these 
CpGs (540,390) were directly probed, including 16,927 (about 
74%) of CGIs. CGIs showed low average levels of methylation 
(< 0.20). The average CpG distribution and DNA methyla-
tion levels across all gene features are plotted in Figure 4. As in 
mammalian genomes, we found that the CpG density gradually 
increased toward transcriptional start site (TSS). Methylation 
shows a negative association with CpG density in this region. 
With increased CpG density toward the TSS, methylation levels 
declined. CpG density reached the highest level at the 5' and 3' of 
splice sites of the first exons, and these promoter-associated CGIs 
susceptible chickens before and after MDV infection. The meth-
ylated compartment in the chicken was detected by digestion 
with five methyl-sensitive restriction enzymes, and the unmeth-
ylated part was investigated by the methyl-dependent enzyme 
McrBC. Using in silico analysis, Methyl-MAPS method theo-
retically covered 3,317,773 CpGs (~32%) in the chicken genome, 
which are recognized by both methyl-dependent and methyl- 
sensitive restriction endonucleases (MR sites). From each sequenc-
ing library, ~26–90 million reads were obtained, with ~50% of 
them mapping to chicken genome. For each sample, methyla-
tion information was obtained for 2.7 to 3.1 million CpG sites. 
Of those, 66–76% of them had coverage greater than 10 reads/
site, which were used for further analysis (Table S2). Most of 
the CpGs were covered by 20–200 reads, and some had a cover-
age greater than 200 (Fig. S5). The MR and CpG site coverage 
were similar among all four samples. With a cutoff of a minimum 
10 reads/site, 57.83–72.11% of MR sites were detected, which 
included 17.03–21.23% of chicken CpG sites (Table S3).
In total, 3,261,294 CpGs were detected by Methyl-MAPS in 
four samples. Among these CpGs, a total of 1,372,926 CpGs were 
annotated as either CGI_promoter, CGI_others, non_CGI pro-
moter, gene body, or repeats. As shown in Figure S6, CpGs were 
Figure 4. cpG distribution and DNA methylation pattern in chicken genes. Average cpG density and methylated cpG density were plotted across all 
genes from the promoter to the end of annotated 3' UTRs.
Figure 5 (See opposite page). Genome-wide DNA methylation profiling. screen shot from Ucsc genome browser tracks of methylation data. The top 
includes the genomic location and annotation information. MR site track indicated potential McrBc and RE cut sites. The bars indicate the absolute 
read counts mapped to the cpG site. The red bars represent cpGs cleaved by McrBc and thus methylated, while the blue indicates cpGs cleaved by 
RE and thus unmethylated. The black denotes cpGs cleaved by both methyl-dependent and methyl-sensitive enzymes that have moderate methyla-
tion levels. The height indicates the number of observances. (A) Genome browser view of the methylation status of the MhcII locus in lines 63 and 72 
before and after MDV treatment. Regions 1 and 2 showed methylation variations in two lines after infection. (B) The methylation status of a region of 
repetitive DNA sequences on chromosome 1. Region 3 and 4 are two examples showing methylation variations induced by MDV infection. It was clear 
that the LTR repeat (region 4) upstream of chicken transcript was less methylated in line 72 than line 63 before MDV infection, whereas its methylation 
was raised in line 72 after the virus challenge.
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Figure 5. For figure legend, see page 436.
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with the hypomethylation of the region detected by Methyl-
MAPS. Detected by both Methyl-MAPS and bisulfite sequenc-
ing, CR1-B methylation levels were similar in line 6
3
 before and 
after infection, showing moderate methylation level (~50% 
methylation). In line 7
2
, the highly methylated CR1-B (0.935 by 
Methyl-MAPS and 75% by bisulfite sequencing) became hypo-
methylated after infection (0.281 by Methyl-MAPS and 25% by 
bisulfite sequencing).
Discussion
DNMTs expression and DNA methylation variations. Virus 
infection and tumorigenesis change DNMTs transcriptional pat-
terns. Compared with the adjacent normal tissues, tumor tissues 
often show abnormal DNMTs mRNA levels.17-19 Infection with 
EBV upregulated DNMT3a expression and decreased expression 
of DNMT1 and DNMT3b.20 Additionally, our lab found that 
DNMT1 was activated in the spleen of susceptible chickens and 
DNMT3b was silenced in resistant chickens after MDV infection 
during MD development.6 These results suggest that expression 
variation of DNMTs is dependent on disease progression, tissue 
and cell type, as well as on the genetics of the host. DNMT3a 
and DNMT3b, two methyltransferases responsible for de novo 
methylation, interact with DNMT1, the methyltransferase for 
maintaining methylation, to establish and spread methylation.21 
Changes in DNMTs expression can influence DNA methylation 
levels;22,23 therefore, it is reasonable to speculate that decreases in 
DNMT3a in infected line 6
3
 may result in the reduction of DNA 
methylation. The overall hypomethylation in MDV-infected 
line 6
3
 was caused by methylation decreases in CGIs, repetitive 
regions and genes. DNMT3a-dependent gene body methylation 
has been shown to promote expression of tissue-specific genes 
in mouse,22 indicating that repressed DNMT3a may be respon-
sible for the methylation reduction in gene body in line 6
3
 and 
a factor contributing to infection resistance. DNMT3b expres-
sion was induced in line 7
2
 after MDV infection, which was 
consistent with the increased methylation levels observed. The 
slight increase in genomic methylation levels in infected line 7
2
 
appeared mostly due to a slight upward shift in the scores rather 
than due to a large number of unmethylated CpGs becoming 
completely methylated. Intricate differences in DNA methyla-
tion existed between MD resistant and susceptible chickens. In 
this study, we found that global methylation levels were higher in 
line 7
2
 than in line 6
3
 prior to MDV infection. More CpGs fell 
into the unmethylated group and fewer were in the methylation 
and intermediate methylation classes in uninfected line 6
3
 than 
in line 7
2
, leading to lower methylation levels in line 6
3
 before 
MDV infection. The lower methylation in line 6
3
 was presum-
ably attributed to lower expression of DNMT1 and DNMT3b. 
Additionally, the higher methylation levels in line 7
2
 may be 
established during selection and inbreeding, and was line spe-
cific, suggesting that initial methylation levels may contribute to 
MD resistance and susceptibility.
Methylation variations and MD resistance/susceptibil-
ity. We also found methylation changes at individual loci that 
may contribute to resistance susceptibility. For example, we 
were unmethylated. Within the coding region, compared with the 
low CpG density and methylation in introns, the internal exons 
and the last exon were enriched on methylated CpGs, and both 
CpG density and methylation reached a maximum level at 5' 
and 3' ends. CpGs were poor in regions coding for 3'UTRs and 
Poly (A) tails, and methylation level in these regions was similar 
to the level found in gene bodies. Repetitive DNA regions con-
tain 950,055 CpGs, about 27.05% of annotated chicken CpGs. In 
the four groups, about 12.35% to 14.78% of detected CpGs were 
found in repetitive DNA sequences, with average methylation at 
0.3 (Table S4).
To validate the genome-wide methylation results, we used 
pyrosequencing and bisulfite sequencing to quantify methylation 
levels in several regions. Five CpG sites in a CGI on chromo-
some 2 (29, 264–29, 264, 968), upstream of HDAC9 (histone 
deacetylase 9), were analyzed by pyrosequencing (Fig. S7A 
and B). Average methylation levels were similar between infected 
and non-infected line 6
3
; in line 7
2
, methylation was significantly 
increased in the infected group. Methyl-MAPS also identified 
enhanced methylation in line 7
2
, which showed methylation 
levels that were almost doubled. A CGI located upstream of 
FABP3 (Fatty acid binding protein 3) was detected as hypo-
methylated, with methylation levels lower than 0.1 among the 
four groups by both methods (Fig. S8A and B)—consistent 
Table 2. Top canonical pathways
IT63_T63 IT72-T72
IGF-1 signaling IL-2 signaling
IL-4 signaling pDGF signaling
prolactin signaling cholecystokinin/gastrin-mediated signaling
IL-2 signaling Non-small cell Lung cancer signaling
Myc mediated apoptosis 
signaling Erythropoietin signaling
Table 3. Top diseases and disorders
IT63_T63 IT72-T72
Gastrointestinal disease cancer
Inflammatory disease Organismal injury and abnormality
Inflammatory response skeletal and muscular disorder
Developmental disorder Reproductive system disease
Organismal injury  
and abnormality
Developmental disorder
Table 1. Before infection DMRs associated biofunction
Canonical pathways Disease and disorder
polyamine regulation in colon cancer Inflammatory response
Interferon signaling Endocrine system disorders
cell cycle: G2/M DNA damage  
checkpoint regulation Inflammatory disorders
iNOs signaling Gastrointestinal disease
Myc mediated apoptosis signaling cancer
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Figure 6. Quantification of 5-hmc content by anti-5-hmc box blot. (A) Dot blot of 10 ug of DNA from thymus with 5-hmc positive controls of 50 ng,  
25 ng and 10 ng DNA. (B) Quantitative measurement of dot blots in (A) using densitometry.
found differential methylation at the MHCII locus between 
line 6
3
 and line 7
2
 before viral infection. Since the MHC 
locus contains several immune-related genes, we believe that 
the pre-established methylation pattern in lines 6
3
 and 7
2
 may 
influence their immunity to MDV infection, and also contrib-
ute to the infection-induced methylation alterations in the two 
chicken lines. To further screen for potential loci of interest, we 
identified DMRs and iDMRs that potentially contribute to dis-
ease resistance or susceptibility and respond to MDV infection. 
For example, we discovered an iDMR at the promoter of MD 
resistance candidate gene GH.24,25 In addition, the enhanced 
transcription levels of CDC42 were coordinated with an 
observed decline in DNA methylation in a nearby DMR before 
and after infection, consistent with the fact that methylation 
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suggest it may contribute to MD susceptibility by deregulation 
of the cell cycle and proliferation. Pathway analysis reveals that 
DMRs were enriched in genes involved in inducible nitric oxide 
synthase (iNOS) signaling, which have been shown to produce 
nitric oxide (NO) to reduce viral replication.28 Biofunctional 
analysis also demonstrated that different pathways may be 
silenced gene transcription.26 Methylation may also regulate 
the transcription of genes involved in the cell cycle pathway, to 
further influence disease resistance and susceptibility. CDC42, 
a small GTPase protein, works with other proteins to modu-
late cell cycle and adhesion.27 The decreased methylation and 
higher transcription level of CDC42 in the infected line 7
2
 
Figure 7. (A) Quantification of viral genome copy numbers. The virus copy numbers were evaluated based on viral gene Meq and ICP4 in MDV infected 
DF-1 cells with or without 5-AZA treatment, and normalized to a single copy gene, Vim. Quantitative results are represented as Mean ± sTD (n = 3).  
(B) The expression of MDV oncogene Meq. The left panel showed the location of nuclei using DApI to stain DNA (blue). The middle panel was the loca-
tion and expression MDV oncoprotein Meq (green). The right panel indicated Meq expression in the MDV infected DF-1 cells with or without 5-AZA.
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methylation level.36 The coverage of CGIs was improved to 74% 
by the current study, including CGIs at the promoters, intragenic 
and intergenic regions with high, low and intermediate methyla-
tion. Through intensive analysis, we found a negative correlation 
between CpG density and DNA methylation at the TSS region 
and a positive association at other regions in chicken, which is 
similar to the methylation patterns identified in human and 
other species.13,36 DNA methylation was depleted at CGI asso-
ciated promoter regions, which has been shown in other verte-
brates to allow transcription factors and RNA polymerase II to 
initiate transcription.38 The analysis and global maps of methyla-
tion obtained in the current study provide a more comprehensive 
understanding and are a source of baseline methylation levels in 
the chicken genome.
Methylation inhibition and MDV replication. From our 
results, it seems that the disturbance of DNA methylation after 
MDV infection did not involve active DNA demethylation 
through the conversion to 5-hmC. Together with the down-
regulated DNMT3a expression, decreased methylation in line 
6
3
 is likely controlled by passive demethylation. Since methyla-
tion levels were lower in line 6
3
 than line 7
2
, DNA methylation 
inhibition presumably improves MD resistance. Methylation 
inhibitor treatment limited MDV replication in vitro, which was 
confirmed by the independent estimation of virus copy numbers 
using ICP4 and Meq. Lower expression of Meq in the drug-treated 
infected cell suggested that 5-AZA either limited viral replication 
and spread or inactivated Meq transcription. However, there is a 
debate about the function of 5-AZA on MDV infection. Meq 
expression was elevated in MDV-infected B lymphocytes trans-
formed with avian leukosis virus (ALV).39 This disagreement 
may be explained by the differences between ALV-transformed 
B cells and the chicken model used. Line 6
3
 chickens are resis-
tant to MD but susceptible to ALV, whereas line 7
2
 chickens are 
resistant to ALV and susceptible to MD.40 Resistance to ALV and 
MDV may be mediated by different mechanisms. Methylation 
inhibition may enhance ALV propagation, which may further 
assist MDV infection. In addition, the promoter of Meq was 
absent of DNA methylation in MDV-infected cells,6 and the 
methylation inhibitor was unable to directly regulate Meq expres-
sion, increasing the possibility that ALV infection favors second-
ary infection with MDV.
In summary, the genome-wide quantitative DNA methylation 
analysis in the current study provides more comprehensive DNA 
methylation maps for chicken as well as global maps of meth-
ylation changes related to MDV infection. Our data suggests 
that lower global methylation levels in the host may be related 
to MD resistance by activating genes with antiviral and antitu-
mor functions. Higher methylation in MD-susceptible chickens 
might favor viral replication and spread by the disruption of 
normal growth and immune responses. These results suggest a 
mechanism of disease resistance determined by DNA methyla-
tion patterns, and support the notion that methylation variation 
could be both a cause and consequence of viral infection. Further 
work is required to functionally link observed gene expression 
and DNA methylation changes. Future combination of this work 
with histone modification analysis will provide a foundation to 
provoked after infection in each line via changes in methyla-
tion status. Myc is known to regulate the immune response 
to infection, and is associated with human cancer and tumor 
development.29 Myc-mediated apoptosis pathway were exclu-
sively found in line 6
3
, suggesting line-specific DNA methyla-
tion variation might affect disease resistance via regulating cell 
death. Given the fact that methylation inhibits gene expres-
sion and the reduction of DNA methylation in line 6
3
, line 6
3
 
specific iDMRs may activate genes controlling inflammatory 
response, which would help eliminate the virus from the host. 
Line 7
2
 iDMRs were associated with genes involved in cancer, 
suggesting DNA methylation may participate in this process, 
although the contribution of DNA methylation in MDV infec-
tion-induced tumorigenesis needs to be further elucidated.
Methylation alterations in repetitive regions. MDV infec-
tion substantially altered the methylation status of repetitive 
DNA sequences. A large reduction in methylation was observed 
on repetitive DNA in line 6
3
, indicating that methylation of 
these elements may be sensitive to viral infection. Repetitive 
DNA can exert regulatory functions on gene activity, and some 
cis-elements have originated from transposable elements (TEs) 
in humans, including LINEs and LTRs.30,31 DNA methylation 
is a determinant of TE mobility, which can affect nucleosome 
binding and regulate nearby gene expression.32,33 Moreover, 
repetitive regions are often hypomethylated in cancer cells, 
resulting in genomic instability.26 In the chicken genome, 
less than 9% of the genome is comprised of interspersed ele-
ments. This is markedly lower than in the mammalian genome, 
which contains 40–50%.34 The lower number of TEs is prob-
ably due to the lack of active elements in the chicken genome.35 
Therefore, it is reasonable to speculate that methylation varia-
tion at chicken TEs potentially influences gene transcription 
rather than TE retrotransposition.35 It has been shown that CR1 
elements upstream of STAT1 (signal transducer and activator of 
transcription 1) and IL12A (interleukin 12A) contain potential 
binding sites for GATA1 (GATA binding protein 1). The meth-
ylation levels on these two elements were downregulated after 
MDV infection, which was coordinated with the upregulation 
of mRNA levels. Since methylation inhibits transcription factor 
binding, decreased methylation at repetitive regions may up or 
downregulate gene expression through the interaction between 
transcriptional activators or repressors and DNA after MDV 
exposure in both chicken lines. Our results also suggest that 
MDV infection changed the methylation levels at repetitive 
DNA, such as CR1 and LTR, which might mediate regulatory 
functions in response to infection.
DNA methylation in chickens. Previously, the chicken meth-
ylome was characterized using MeDIP-seq, an antibody bind-
ing affinity-based method.36 However, this method is biased 
toward highly methylated CpG-rich regions and provides lower 
resolution and coverage.12,36,37 In the current study we applied 
Methyl-MAPS, which allowed quantification of methylation 
at single copy and repetitive regions and avoided the bias due 
to the differences in methylation level or CpG density.13 The 
MeDIP method only analyzed about 9–13% methylated CGIs 
in chicken genome, and was unable to detect CGIs with low 
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(QIAGEN) to remove dNTPs, and quantified by Qubit dsDNA 
Broad-Range Assay (Invitrogen). Endogenous EcoP15I sites were 
then methylated using EcoP15I enzyme with 1 × NEB buffer 3, 
1 × BSA, 360 μM SAM. The methylation reaction was per-
formed at 37°C for 2–3 h, and then boosted with additional 
EcoP15I, NEB buffer 3, BSA, and SAM for another 2–3 h at 
37°C. The DNA was purified using QIAquick spin columns 
(QIAGEN). The EcoP15I cap adaptor (50 pmol/μl) was ligated 
to the end-repaired and EcoP15I methylated DNA using Quick 
Ligation Kit (NEB), and purified using MinElute (QIAGEN) to 
remove excess adapters.
DNA samples were size fractionated using a 1% agarose 
gel. DNA was selected based on 7 fragment sizes: 0.8–1.1 kb, 
1.1–1.5 kb, 1.5–2 kb, 2–3 kb, 3–5 kb, 5–8 kb and > 8 kb. 
Each fraction was purified using QIAquick Gel Extraction kit 
(QIAGEN). DNA from each fraction was then circularized with 
a biotin labeled T30 sticky linker using the Quick Ligation Kit 
(NEB) and purified using QIAquick spin columns (QIAGEN). 
Fractions were combined into two tubes, one for < 2 kb and the 
other for > 2 kb. Circularized DNA was isolated using ATP-
dependent Plasmid-safe DNase (Epicenter) to degrade the linear 
DNA. The purified DNA samples were digested with EcoP15I 
to release mate-pair tagged fragments. The digested DNA was 
repaired by Klenow (NEB), and then heat inactivated at 65°C 
for 20 min. P1 and P2 adapters were added to the end repaired 
DNA using Quick Ligation Kit (NEB). P2 adapters contained 
distinct barcodes for each library so libraries can be later pooled 
for sequencing. The < 2 kb and > 2 kb fractions were combined 
together for library purification.
Libraries were bound to M280 streptavidin beads (Invitrogen) 
through the biotin on the T30 internal adaptor. Washed library-
bound beads were nick translated. Trial PCR was performed by 
serial dilution of beads to ensure the existence of 156-bp products 
and to determine the sufficient cycles to obtain enough products. 
Final libraries were amplified using all the beads and Phusion 
High Fidelity DNA Polymerase (NEB) with 19–23 cycles. The 
PCR products were combined together for ethanol precipitation.
A 6% DNA PAGE gel (Lonza) was used to purify the 
156-bp library DNA. The final library DNA concentration was 
measured using the Qubit HS assay kit (Invitrogen), and the 
quality and quantity was assessed by Bioanalyzer DNA 1000 
LabChip (Agilent).
DNA sequencing. The DNA libraries were sequenced by 
EdgeBio on an ABI SOLiD 4 system according to the manufac-
turers instructions for 25 base-pair mate-pair sequencing. Eight 
libraries from 4 samples were pooled and sequenced on a single 
chip using the standard SOLiD protocol.
Tag mapping and data analysis. Barcoded sequences were 
separated using a custom perl script that allows for error checking 
in the barcode sequence subsequent analysis steps were performed 
as in Edwards et al. In brief, sequence tags were mapped using 
SOLiD system software analysis package Corona-lite (Applied 
Biosystem). Two mismatches in each 25 bp read to the chicken 
genome (galGal3, http://genome.ucsc.edu) were allowed. Reads 
were filtered to remove fragments without at least one enzyme 
cut site on the fragment end. Read counts were normalized as 
understand the role of epigenetics in the crosstalk between virus 
and host through the regulation of gene expression. Additionally, 
the comprehensive integration of both genetic and epigenetic 
information will help identify candidate genes implicated in 
disease resistance or susceptibility, improve our understanding 
of epigenetic predisposition to viral infection, and give clues for 
potential epigenetic therapies.
Materials and Methods
Experimental animals and sample preparation. Line 6
3
 and line 
7
2
 (USDA-ARS Avian Disease and Oncology Laboratory) are 
two highly inbred lines of specific-pathogen-free white leghorn 
chickens that are resistant and susceptible, respectively, to MD 
tumors. Chickens from each line were separated into two groups. 
One group was infected with a very virulent (vv+) strain of MDV 
(648A passage 40) at day 5 after hatching, while the other group 
did not receive MDV. Four chickens were selected from each 
group at 21 DPI, and none of them developed tumors during the 
experiment period. Fresh thymus samples were harvested indi-
vidually and stored in RNAlater solution (QIAGEN) at -80°C 
for DNA or RNA extraction. The entire animal experiment was 
conducted following the procedures and guidelines described in 
the “Guidelines for Animal Care and Use” manual approved by 
the Animal Care and Use Committee, the USDA-ARS, and the 
Avian Disease and Oncology Laboratory (Approval ID 111-26).
DNA preparation and endonuclease digestion. Genomic 
DNA from four samples of each treatment group was extracted 
using the Wizard Genomic DNA purification kit (Promega). 
RNase treatment was performed to remove RNA. DNA concen-
tration was measured by the Qubit dsDNA Broad-Range Assay 
(Invitrogen).
Four DNA samples from each group were pooled together with 
equal amounts. Methyl-MAPS libraries were made as in Edwards 
et al. with slight modification. In brief, the pooled samples were 
separated into two parts, and were digested by methyl-depen-
dent (McrBC) or 5 methyl-sensitive restriction enzymes (HpaII, 
HpyCH4VI, AciI, HhaI and BstUI), respectively (New England 
Biolabs, referred to as RE). The amount of starting DNA was 15 
ug for both RE and McrBC digestions. Three rounds of McrBC 
digestion were performed to assure complete digestion of methyl-
ated DNA. For the first two rounds, DNA was extracted using 
phenol-chloroform extraction and ethanol precipitation. After 
the last round of digestion, DNA was purified using QIAquick 
spin columns (QIAGEN) to remove residual GTP. Four rounds 
of RE digestion were conducted and followed by phenol-chloro-
form extraction and ethanol precipitation. The first round of RE 
was set up with HpaII and HpyCH4IV, the second round with 
AciI and HhaI, the third round with BstUI and the fourth with 
HpaII and HpyCH4IV. Samples were purified by phenol-chloro-
form extraction and ethanol precipitation between each round.
SOLiD mate-pair library construction. Mate-pair libraries 
were prepared with slight variation to the SOLiD library prepa-
ration guide according to the protocol in Edwards et al. In brief, 
fractionated DNA was repaired using End-It DNA End-repair kit 
(Epicenter), subsequently purified using QIAquick spin columns 
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of 6.6 M Ammonium acetate. DNA samples were then loaded 
on a nitrocellulose membrane (Bio-rad), and UV cross-linked. 
Blocking was performed using 10% non-fat milk. The membrane 
was incubated with primary antibodies against 5-mC (Active 
Motif) and 5-hmC (Diagenode), and diluted in blocking solu-
tion (1:5,000) at 4°C overnight. After 3 washes, the membrane 
was incubated with anti-rabbit IgG and anti-mouse IgG second-
ary antibodies (Santa Cruz) and diluted in TBST (1:5000) for 
1 h at room temperature. Membranes were developed with ECL 
(Amersham) and measured using ChemiDoc XRS (Bio-Rad). 
Each dot was circled, and the average volume in the circle was 
exported to Excel to estimate 5-mC and 5-hmC contents using 
Quantity One software (Bio-rad). 5-mC and 5-hmC positive 
controls were synthesized by PCR using 5-mCTPs and 
5-hmCTPs (ZMYO research).
Cell culture and MDV infection. The chicken embryo fibro-
blast cell line DF-1 was grown in Dulbecco’s modified Eagle’s 
medium supplemented with 10%, fetal bovine serum, strepto-
mycin (100 mg/ml) and penicillin (100 U/ml) (Invitrogen). 
Cells were maintained at 37°C in humidified 5% CO
2
 condi-
tions. The very virulent + (vv +) strain of MDV (648A passage 
40) was obtained from USDA-ARS Avian Disease and Oncology 
Laboratory. The DF-1 cells were inoculated with the virus at 
multiplicity of infection (M.O.I) of 0.1 for 3 d. The DNA meth-
ylation inhibitor 5-azacytidine (Fisher) was used to treat the 
infected cells at concentration of 5 μM.
Immunofluorescence. The DF-1 cells were fixed with 4% 
of paraformaldehyde for 15 min, and permeabilized using 
0.5% Triton-X 100 in PBS for 15 min. Primary antibodies were 
prepared at 1:500 and 1:1000 dilutions in PBS, and incubated 
with cells for 1 h. After washing the cells 3 times, FITC-labeled 
donkey anti-mouse or donkey anti-rabbit IgG secondary anti-
bodies were diluted 1:1,000 in PBS, and incubated with cells 
for 30 min. The nuclei were labeled with 4', 6-diamidino-2- 
phenylindole (DAPI) (Invitrogen). The immunoreactive com-
plexes were visualized with a Zeiss LSM 510 confocal fluores-
cence microscope, and the images were processed using LSM 
Image Examiner software (Zeiss).
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Acknowledgments
Thanks to Dr Yanghua He for figures and Dr Hans H. Cheng 
for the precious discussion of this manuscript. F.T. and J.H. 
performed Methyl-MAPS experiment, did the validation of the 
results by Q-PCR, analyzed some of the result and wrote the 
paper. F.Z., N.V. and J.E. analyzed the data. Z.H. did the micro-
array experiment and collected the samples and helped revised the 
manuscript. Z.K.J. and J.Z.S. designed and revised this paper.
Supplemental Materials
Supplemental materials may be found here: 
www.landesbioscience.com/journals/epigenetics/article/24361
in Edwards et al.13 The methylation level for each CpG site 
was calculated as the number of reads from methylation (RE) 
library divided by the number of reads from both RE and McrBC 
libraries.
Each CpG site was annotated according to its genomic loca-
tion (promoter, gene body, intergenic, repetitive regions and 
CpG islands). Fisher’s Exact test was used to identify the differ-
ential methylation at individual CpG sites while controlling for 
an FDR less than 0.01. The annotation information, including 
Refseq, repeatMask, CpG islands were obtained from the UCSC 
genome browser (galGal3). Sites of differential methylation were 
defined as the absolute methylation level difference for each CpG 
between infected and non-infected sample greater than 0.3. 
Infection induced differential methylation regions (iDMRs) were 
discovered by merging adjacent sliding windows with at least 3 
differentially methylated CpGs in a 2 kb window. DMRs were 
reported only if their length was greater than 3 kb.
Bisulfite conversion, pyrosequencing and bisulfite sequenc-
ing. Sodium bisulfite conversion reagents were used to treat 500 
ng of DNA (EZ DNA Methylation Golden Kit) using the stan-
dard protocol provided by the manufacturer. PCR primers for 
methylation validation were listed in Table S4. For pyrosequenc-
ing, we used biotin labeled universal primer in the PCR reaction. 
The bisulfite PCR included 1 μl of 1:5 diluted bisulfite converted 
DNA, primers and PCR reagents from Hotstar Taq polymerase 
kit (QIAGEN) with four biological replicates. The methylation 
level was detected individually by Pyro Q-CpG system (PyroMark 
ID) using 20 μl of PCR products. For bisulfite sequencing, an 
equal amount of DNA from four samples of treated or control 
groups from each chicken line were pooled together, serving as a 
template for the bisulfite conversion and the bisulfite PCR, and 
then PCR products were purified (QIAquick Gel Extraction Kit, 
QIAGEN). The purified PCR products were ligated to pCR® 
2.1 Vector (The Original TA cloning® Kit, Invitrogen), trans-
formed to DH5α competent cells (ZYMO Research), and 
screened for successful insertions (blue-white selection) after 
incubation at 37°C overnight. Ten white colonies from each 
group were cultured in a 37°C shaker overnight. Plasmid DNA 
was isolated using the QIAprep® Miniprep Kit (QIAGEN), and 
M13 reverse primer was used for sequencing.
Purification and quantification of mRNA levels. RNA was 
extracted from four samples per group using the RNeasy Mini Kit 
(QIAGEN) and the standard method described by the manufac-
turer. An on-column DNase digestion was performed to remove 
any contaminant DNA. RNA concentration was measured by 
Nanodrop. Reverse transcription was performed on 1 μg of puri-
fied total RNA using SuperScript™ III Reverse Transcriptase 
(Invitrogen) with oligo (dT) 12–18 primers (Invitrogen); mRNA 
levels were quantified using SYRB Green PCR Kit (QIAGEN) 
with four biological replicates from each group. PCR primers for 
mRNA quantification are listed in Table S4.
DNA dot blot. DNA samples were mixed with 0.1 volume 
of 1 M NaOH, denatured at 99°C for 5 min, and snap cooled 
on ice. The denatured DNA was neutralized with 0.1 volume 
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